As we age, the composition and function of the gut microbiome, the integrity of the intestinal barrier and systemic immune regulation change. These changes are closely linked to the concept of “inflammaging” – a chronic, low-grade inflammatory activation that affects several hallmarks of aging, including mitochondrial dysfunction, cell senescence and neuroinflammation. At the level of the gut-brain axis, data are accumulating that microbiome-associated mechanisms can modulate mood, stress processing, cognitive function and the risk of neurodegenerative diseases via immune, neuroendocrine and neuronal signaling pathways.
Publikation
- Longevity-Special
You May Also Like
- Evidence, pathophysiology and management in the light of current data
Heart failure with improved ejection fraction (HFimpEF)
- Early rheumatoid arthritis
C1M has potential as a biomarker
- Osteoporosis
Risk-stratified therapy with osteoanabolic agents improves outcomes
- "Swiss Health Care Atlas"
New indicator: medication for weight regulation
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Longevity Medicine 2025
From anti-ageing to precision prevention
- Treatment of pancreatitis: current study data
How can the risk-benefit profile be improved?
- Prurigo and PN